Author's Response to Letter to Editor on Characteristics and Outcomes of Middle East Respiratory Syndrome Coronavirus Patients Admitted to an Intensive Care Unit in Jeddah, Saudi Arabia

Journal of Intensive Care Medicine

Volumn 31, Issue 4, 2016, Pages 289-

  Wahla, Ali S ^a  

^a HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN;

CLINICAL FEATURE; COMORBIDITY; CORONAVIRIDAE INFECTION; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LETTER; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SAUDI ARABIA; SURVIVAL; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; ACUTE RESPIRATORY FAILURE; EARLY DIAGNOSIS; INFECTION CONTROL; RESPIRATORY TRACT DISEASE; SURVIVAL TIME; HOSPITALIZATION;

HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SAUDI ARABIA;

EID: 84963621198     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066615598721     Document Type: Letter

References (3)

1. Zumla A, Hui DS, Perlman S,. Middle East respiratory syndrome [published online June 3, 2015]. Lancet. 2015; pii: S0140-6736 (15) 60454-8.
2. Zielecki F, Weber M, Eickmann M, et al. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol. 2013; 87 (9): 5300-5304.
3. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA,. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014; 20: 42-46.